期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Relationship between inter-α-trypsin inhibitor heavy chain 4 and ovarian cancer 被引量:2
1
作者 Min Huang Wei Zhang +1 位作者 Bingbing Zhao Li Li 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2019年第6期955-964,共10页
Objective:The inter-α-trypsin inhibitor heavy chain 4(ITIH4)protein is involved in the development of tumors.However,the relationship between ITIH4 and ovarian cancer(OC)has not been extensively examined.This study a... Objective:The inter-α-trypsin inhibitor heavy chain 4(ITIH4)protein is involved in the development of tumors.However,the relationship between ITIH4 and ovarian cancer(OC)has not been extensively examined.This study aimed to explore the effect of ITIH4 on OC and to identify its underlying mechanism.Methods:Expressions of ITIH4 in OC tissues and cells were determined using quantitative reverse transcription polymerase chain reaction(RT-qPCR)and western blots.The function of ITIH4 in the OC cell line HO8910 pm was tested via ITIH4 knockdown.The cell growth rate was measured using MTT and colony formation assays.Flow cytometry was performed to evaluate cell cycle progression.Cell migration and invasion abilities were observed using the transwell migration assay.Results:ITIH4 was downregulated in OC tissues and cells.ITIH4 knockdown promoted cell growth and cell cycle progression.Consistent with these results,inhibition of ITIH4 in OC cells significantly increased cell migration and invasion abilities.Cox regression analysis suggests that ITIH4 expression alone is not a good predictor of the prognosis of malignant ovarian tumors in patients.Conclusions:ITIH4 inhibits the progression of OC,suggesting that ITIH4 may be a useful biomarker for OC.This study may provide a potential novel target for the treatment of OC. 展开更多
关键词 Ovarian cancer inter-α-trypsin inhibitor H4 protein quantitative reverse transcription PCR RNAI
下载PDF
ITIH4在卵巢组织中的表达及临床意义初探 被引量:1
2
作者 黄敏 王琪 +2 位作者 张玮 阳志军 李力 《现代妇产科进展》 CSCD 2013年第7期542-545,共4页
目的:研究人α胰蛋白酶H4重链(ITIH4)mRNA在卵巢肿瘤组织中的表达情况,探讨其与卵巢癌发生进展的关系。方法:采用实时荧光定量PCR技术检测ITIH4mRNA在80例卵巢癌、24例卵巢良性肿瘤、26例正常卵巢组织中的表达。结果:ITIH4mRNA在卵巢癌... 目的:研究人α胰蛋白酶H4重链(ITIH4)mRNA在卵巢肿瘤组织中的表达情况,探讨其与卵巢癌发生进展的关系。方法:采用实时荧光定量PCR技术检测ITIH4mRNA在80例卵巢癌、24例卵巢良性肿瘤、26例正常卵巢组织中的表达。结果:ITIH4mRNA在卵巢癌、卵巢良性肿瘤及正常卵巢组织中的相对表达量分别为0.0272±0.0130,0.3188±0.1968和1.5429±0.5756;卵巢良性肿瘤组与卵巢癌组、正常卵巢组比较均无显著差异(P>0.05);而卵巢癌组显著低于正常卵巢组(P<0.05)。ITIH4 mRNA表达与卵巢癌的组织学类型、临床分期及腹膜后淋巴结转移有关(P<0.05);而与患者生存率无关(P>0.05)。COX模型分析显示,ITIH4不是卵巢癌患者预后的独立因素。结论:ITIH4 mRNA表达下调可能与卵巢癌的发生和进展有关。 展开更多
关键词 卵巢癌 inter-α-trypsininhibitorh4 实时荧光定量PCR
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部